OCUL

Ocular Therapeutix, Inc.

9.94

USD

OCUL Earnings Reports

Positive Surprise Ratio

OCUL beat 18 of 40 last estimates.

45%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

$16.45M

-$0.33

Implied change from Q3 25 (Revenue/ EPS)

+13.11%

-13.16%

Implied change from Q4 24 (Revenue/ EPS)

-3.70%

+17.86%

Ocular Therapeutix, Inc. earnings per share and revenue

On Nov 04, 2025, OCUL reported earnings of -0.38 USD per share (EPS) for Q3 25, missing the estimate of -0.37 USD, resulting in a -1.60% surprise. Revenue reached 14.54 million, compared to an expected 14.92 million, with a -2.51% difference. The market reacted with a -4.47% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 15 analysts forecast an EPS of -0.33 USD, with revenue projected to reach 16.45 million USD, implying an decrease of -13.16% EPS, and increase of 13.11% in Revenue from the last quarter.

FAQ

What were Ocular Therapeutix, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Ocular Therapeutix, Inc. reported EPS of -$0.38, missing estimates by -1.6%, and revenue of $14.54M, -2.51% below expectations.

How did the market react to Ocular Therapeutix, Inc.'s Q3 2025 earnings?

The stock price moved down -4.47%, changed from $11.41 before the earnings release to $10.90 the day after.

When is Ocular Therapeutix, Inc. expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Ocular Therapeutix, Inc.'s next earnings report?

Based on 15 analysts, Ocular Therapeutix, Inc. is expected to report EPS of -$0.33 and revenue of $16.45M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.